Signature Wealth Management Partners LLC Sells 75 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Signature Wealth Management Partners LLC trimmed its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 0.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 7,947 shares of the financial services provider’s stock after selling 75 shares during the period. iShares Biotechnology ETF makes up about 0.7% of Signature Wealth Management Partners LLC’s investment portfolio, making the stock its 26th largest holding. Signature Wealth Management Partners LLC’s holdings in iShares Biotechnology ETF were worth $1,051,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Darwin Wealth Management LLC bought a new stake in iShares Biotechnology ETF in the 3rd quarter worth approximately $29,000. Highline Wealth Partners LLC purchased a new position in shares of iShares Biotechnology ETF in the 3rd quarter worth $30,000. Ashton Thomas Securities LLC bought a new stake in shares of iShares Biotechnology ETF in the third quarter worth $36,000. Modus Advisors LLC bought a new stake in shares of iShares Biotechnology ETF in the fourth quarter worth $41,000. Finally, Voisard Asset Management Group Inc. purchased a new stake in iShares Biotechnology ETF during the third quarter valued at $59,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ:IBB opened at $138.16 on Wednesday. The stock’s 50-day simple moving average is $136.25 and its two-hundred day simple moving average is $141.72. iShares Biotechnology ETF has a 52-week low of $123.60 and a 52-week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.